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Nagelberg et al. show that the progenitors
for the arteries of the heart arise from a
small population of mesodermal cells,
which require the transcription factors
Tcf21 and Nkx2.5 for their specification.
In the absence of these cells, the heart
arteries are formed by other endothelial
cells, pointing to an unexpected vascular
plasticity.
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The pharyngeal arch arteries (PAAs) are a series of
paired embryonic blood vessels that give rise to
several major arteries that connect directly to the
heart. During development, the PAAs emerge from
nkx2.5-expressing mesodermal cells and connect
the dorsal head vasculature to the outflow tract
of the heart. Despite their central role in establishing
the circulatory system, the embryonic origins of the
PAA progenitors are only coarsely defined, and the
factors that specify them and their regenerative po-
tential are unclear. Using fate mapping and mutant
analysis, we find that PAA progenitors are derived
from the tcf21 and nkx2.5 double-positive head
mesoderm and require these two transcription fac-
tors for their specification and survival. Unexpect-
edly, cell ablation shows that the tcf21+; nkx2.5+
PAA progenitors are not required for PAA formation.
We find that this compensation is due to the replace-
ment of ablated tcf21+; nkx2.5+ PAA cells by endo-
thelial cells from the dorsal head vasculature.
Together, these studies assign the embryonic origin
of the great vessel progenitors to the interface be-
tween the pharyngeal and cardiac mesoderm, iden-
tify the transcription factor code required for their
specification, and reveal an unexpected plasticity in
the formation of the great vessels.
INTRODUCTION
During vascular development, endothelial cells invade the
pharyngeal arches to form the arteries that will connect the heart
to the dorsal aorta and establish the circulatory system of the
embryo [1]. In mammals, the posterior pharyngeal arch arteries
3–6 (pPAAs) are subsequently remodeled to form the great ves-
sels—the carotid arteries, the aortic arch, and the pulmonary ar-
teries [2, 3]—and improper formation of the great vessels results
in cardiac birth defects in humans [4]. Fate mapping studies in
fish and mice indicate that cells in the secondary heart field
contribute to the head and heart muscles and the endotheliumCurrent Biology 25, 2099–of the pharyngeal arch arteries. In mice, clonal analysis suggests
that distinct progenitor pools give rise to distinct portions of head
and heart muscles [5–7]. In mice and fish, nkx2.5-expressing
mesoderm gives rise to heart muscle as well as pPAA endothe-
lium [8]. Together, these observations suggest that the head
muscles, the heart, and the pharyngeal arch arteries share a
common origin. This idea is also supported by overlapping
gene expression patterns and genetic requirements in these
head structures; several transcription factors and signaling mol-
ecules are co-expressed in head muscles, the heart, and the
pharyngeal arch arteries [9, 10], and some of these are required
in the progenitors of all three tissues to promote correct head
muscle, heart, and pharyngeal arch artery formation [11–13]
[14]. Similarly, the co-occurrence of craniofacial and cardiac
birth defects also supports the idea of a shared origin of head
structures and the heart [4, 15, 16]. For example, key features
of the DiGeorge Syndrome are cardiac abnormalities, abnormal
facies, and a cleft palate [17]. Together, these studies suggest
that the pharyngeal arch arteries are derived from a large meso-
dermal population that also gives rise to head and heart muscle
(reviewed in [18]). However, despite these observations, the
exact origin of the pPAAs, the mechanism of their specification,
and their regenerative potential remain unclear.
Here, we show that the pPAA progenitors arise from a small
population of head mesodermal cells that co-express the
cardiac marker nkx2.5 and the head myoblast marker tcf21.
Consistent with this expression profile, we find that the pPAA
progenitors also require the transcription factors nkx2.5 and
tcf21 for their specification. However, in the absence of the
pPAA progenitors, the pPAAs still form. We find that this surpris-
ing vascular plasticity is possible due to neighboring endothelial
cells that migrate in and replace the missing pPAAs.
RESULTS
tcf21+ Cells Contribute to Head Muscles, the Ventral
Head Vasculature, and the Heart
To understand the role of the pharyngeal mesoderm in pPAA
development, we sought a genetic marker to visualize and
manipulate this tissue [19]. Consistent with observations in
chicken and mice [20–22], we find that the transcription factor
tcf21 (Epicardin/Capsulin/Pod1) is expressed bilaterally at the
12-somite stage (15 hours postfertilization, hpf) in two domains
within the head mesoderm—an anterior domain and a posterior2110, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2099
Figure 1. Expression of tcf21 during Head
Formation
(A–C) Staining of tcf21mRNA inwild-type embryos
of indicated stages. n > 7.
(D–I) Images of fixed embryos of the indicated
stages and genotypes stained for mCherry and
ZsYellow proteins (D–F) or mCherry and GFP (G–I).
White squares in (D) and (E) indicate region shown
with increased intensity to demonstrate domain
overlap in insets in (D) and (E). sox10:GFP was
used to mark the neural crest contribution to the
pharyngeal arches. Arrows in insets indicate re-
gion where tcf21 and nkx2.5 are co-expressed.
n = 5 for (D) and (E); n = 1 for (F); n = 5 for (G); n = 2
for (H); n = 1 for (I).
(J) Staining of pitx2 mRNA and mCherry protein in
a 15-somite stage embryo (n = 13).
(K) Schematic summary of pitx2, tcf21, and nkx2.5
expression in the headmesoderm in the 14-somite
stage embryo. Note that in this study, the term
‘‘head mesoderm’’ refers to the mesoderm
comprised of the prechordal plate mesoderm, the
pharyngeal mesoderm, and the cardiac meso-
derm.Pitx2, tcf21, and nkx2.5mark—possibly only
parts of—the prechordal plate, pharyngeal meso-
derm, and pharyngeal mesoderm/secondary heart
field mesoderm, respectively.
(L–M0 0) Live images of 60 hpf embryos carrying
indicated transgenes. Square in (L) indicates
magnified region in (M). (M0) and (M0 0 ) show single
fluorescent channels. Arrows in (M) indicate some
of the tcf21+ muscles. Note that the prechordal
plate-derived extraocular muscles (asterisk in M)
and the somite-derived sternhyoideus muscles
(arrowhead in M) do not express tcf21.
(N–O0 0 ) Live images of 38 hpf embryo carrying
indicated transgenes. Square in (N) indicates
magnified region in (O). (O0) and (O0 0) show single
fluorescent channels. Arrowhead in (N) indicates
the HA progenitors. Arrows in (O) indicate tcf21+
pPAA progenitors, and the numbers label the
arches. Note that the flk:GFP transgenic line
weakly labels the pharyngeal endoderm and that
PAA3 has already formed and lumenized and
therefore is difficult to see in this projection.
Scale bars represent 100 mm (A–J, L, and M) or
50 mm (N andO). Anterior is to the left. Dorsal views
(A, B, D, E, G, H, and J) and lateral views (C, F, I,
and L–O).domain (Figure 1A). Using tcf21:mCherry-NTR (referred to as
tcf21:mCherry if not indicated otherwise), a transcriptional
reporter for tcf21+ cells [23], we find that at the 14-somite
stage (16 hpf), the anterior tcf21 expression domain is bounded
anteriorly by the prechordal plate mesoderm marked by pitx22100 Current Biology 25, 2099–2110, August 17, 2015 ª2015 Elsevier Ltd All rights reserved[24] and overlaps posteriorly with the
cardiac mesoderm marked by a tran-
scriptional reporter for nkx2.5 (nkx2.5:
ZsYellow) [8, 25] (Figures 1D, 1J, and
1K). Theposterior domain of tcf21 expres-
sion overlaps anteriorly with the nkx2.5-
expressing domain (Figures 1D and 1E;
Movie S3). During the next day, tcf21expression refines to the cores of the pharyngeal arches, where
it is surrounded by neural crest cells, and splits into dorsal and
ventral clusters, which then divide further into smaller clusters
(Figures 1G–1I). Later, mCherry from the tcf21:mCherry
transgene labels most of the head muscles (Figures 1L, 1M,
Figure 2. tcf21+ Cells Contribute to the
Head Muscles, the Head Vasculature, and
the Outflow Tract of the Heart
(A) Schematic representation of fate-mapping
experiment. Images modified from [29].
(B) Image of tcf21:CreER; bactin2:RSG embryo
stained for Myosin Heavy Chain and GFP to mark
the head muscles and the Cre reporter, respec-
tively.
(C and D) Image of tcf21:CreER; bactin2:RSG
embryo stained for Cdh5 and GFP to mark the
vasculature and the Cre reporter, respectively.
Square in (C) indicates magnified region in (D)
(n = 8).
(E) Summary of tcf21+ cell contributions to
different tissues in wild-type embryos and in tcf21
mutant embryos assessed by live confocal mi-
croscopy (wt embryos, n = 95; tcf21/ embryos
n = 34).
Scale bars represent 100 mm (B and C) and 10 mm
(D). Anterior is to the left. Ventral views. From left to
right: PA1, pharyngeal arch 1-derived skeletal
muscle; PA2, pharyngeal arch 2-derived skeletal
muscle; PA 3–6, skeletal muscle derived from PAs
3–6; pPAAs, pharyngeal arch arteries 3–6; HA,
hypobranchial artery; VA, ventral aorta; other, other vascular labeling; OFT, outflow tract (myocardium, endothelium, smooth muscle, or epicardium); VM,
ventricle (myocardium, endothelium, smooth muscle, or epicardium); other, cells derived from tcf21-expressing progenitors that we cannot unambiguously
assign to a specific tissue.and 4A–4D) as suggested previously [20–22, 26, 27]. However,
mCherry also labels some of the dorsal and most of the ventral
head vasculature, including part of the lateral dorsal aorta
(LDA), the hypobranchial arteries (HAs), the pPAAs, and parts
of the ventral aorta (VA) (Figures 1N, 1O, 4Q–4T, and 5A–5D).
As this part of the head vasculature does not express tcf21
once formed, it is likely labeled by mCherry protein that perdures
in the descendants of tcf21+ cells. Together, this indicates that
tcf21 marks two populations of the head mesoderm and sug-
gests that these two cell populations give rise to part of the mus-
cles and vasculature of the head. To test this idea, we followed
the fate of tcf21+ cells using Cre-mediated fate mapping. We
generated embryos that express tamoxifen-inducible CreERT2
recombinase from the tcf21 promoter (tcf21:CreERT2) [27] and
carry the bactin2:RSG indicator line (bactin2:loxP-DsRed-
STOP-loxP-EGFP), which switches from RFP to GFP expression
after excision of the loxP-flanked RFP sequence [28]. We incu-
bated these double transgenic embryos with 4-hydroxytamoxi-
fen (4-HT) from 9 to 24 hpf and scored for the presence of
GFP clones at 4.5 days postfertilization (dpf) (Figure 2A). Consis-
tent with the labeling of the muscles and the vasculature of the
head by mCherry protein perdurance from the tcf21:mCherry
transgene (Figures 1L–1O), this protocol labeled cells with GFP
in pharyngeal arch-derived head muscles, in the endothelial cells
of pPAAs 3–6, the HA, and the VA, as well as tissues in the car-
diac outflow tract and ventricle (Figures 2B–2E). This corrobo-
rates the idea that tcf21+ cells give rise not only to part of the
head muscles but also to the ventral head vasculature.
tcf21+ Cells Are Required for Head Muscle Formation
but Not for PAA Formation
Our finding that most of the muscles and ventral vasculature of
the head are derived from tcf21+ progenitors suggests thatCurrent Biology 25, 2099–tcf21+ cells should be required for formation of these tissues.
To determine whether this prediction holds true, we analyzed
embryos expressing a codon-optimized version of the bacterial
enzyme nitroreductase (NTRo) from the tcf21 promoter
(tcf21:mCherry-NTR) [23]. NTR converts the non-toxic prodrug
metronidazole (Mtz) to a cytotoxic, DNA-crosslinking agent.
The NTR-Mtz system has been used successfully to ablate spe-
cific cell types in zebrafish larvae [30, 31]. We bathed
tcf21:mCherry-NTR embryos in Mtz from 9 hpf to 48 hpf (Fig-
ure 3A) and found in most embryos that tcf21+ cells, labeled in
red by the tcf21:mCherry-NTR transgene, died between 36 hpf
to 38 hpf (Figure S1A). No dying cells were observed in DMSO-
treated tcf21:mCherry-NTR embryos or Mtz-treated non-trans-
genic embryos. Using this approach, we ablated tcf21+ cells in
tcf21:mCherry-NTR embryos also carrying the muscle-specific
a-actin:GFP transgene. In such embryos, all pharyngeal arch-
derived head muscles were lost while the eye and neck muscu-
lature was not affected (Figures 3B–3I, 3D0, 3E0, 3H0, and 3I0),
and the cartilage was deformed but correctly patterned (Figures
S1B–S1E). This is consistent with previous fate mapping
studies which place the origin of the eye muscles in the prechor-
dal plate mesoderm [32–34] and the origin of the neck muscles
mostly in the somitic mesoderm [5, 35]. In stark contrast to the
complete ablation of the pharyngeal head muscles, the ventral
head vasculature was only slightly impaired in Mtz-treated tcf21:
mCherry-NTR embryos at 5 dpf. Mtz-treated tcf21:mCherry-
NTR embryos carrying the endothelium-specific flk:GFP trans-
gene form the LDA, the VA, and all pPAAs (Figures 3J–3Q, 3L0,
3M0, 3P0, and 3Q0). By contrast, the HA is mostly missing and al-
ways fails to connect to the LDA (Figures 3N–3Q, 3P0, and 3Q0;
Table S1).
The failure to ablate the ventral head vasculature is not due to
the failure to ablate the tcf21+ cells because fluorescent protein2110, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2101
Figure 3. tcf21+ cells Are Required for Head Muscle Formation but Not for Head Vasculature Formation
(A) Schematic representation of tcf21+ cell ablation experiment. Images modified from [29].
(B–Y0) Live images and schematic diagrams of embryos of indicated stages carrying indicated transgenes treated with the vehicle control DMSO or Mtz as
depicted in (A). Note that in (F)–(I), the prechordal plate-derived extraocular muscles (arrows in F–I) and the somite-derived sternohyoideus muscles (asterisks in
F–I, H0, and I0) are not ablated. Arrows in (J–Q, L0, andM0) indicate theHA; arrowheads point to the loop formed by the PAA 1 and the opercular artery, and numbers
indicate PAAs 3–6. Note that the HA is missing in the tcf21+ cell-ablated embryos. Note that in (V)–(Y) (schematic diagrams X0 and Y0), all nkx2.5+ cells outside of
the heart and pericardium are ablated. The light green color in (T0) and (U0) marks the nkx2.5+ head muscles. The nkx2.5+ endothelial cells are indicated by dark
green. The scale bar represents 100 mm. Anterior is to the left. Lateral views (first, third, and fifth column) and ventral views (second, fourth, and sixth column).
Sample number of imaged embryos is indicated as a total for the ventral and lateral views. See also Figure S1.
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Figure 4. Specification of the Ventral Head Muscles Requires Tcf21 Activity
(A–X0) Live images and schematic diagrams of embryos of indicated stages and genotypes carrying the indicated transgenes. In mutants, most muscles ex-
pressing tcf21 are absent or severely reduced (A–H, C0, D0, G0, H0). Extraocular muscles (arrows in E–H) and sternohyoideus muscles (asterisks in E–H, G0, H0) do
not express tcf21 and are not affected in tcf21mutant embryos. Arrowheads in (R)–(T) and (V)–(X) indicate the HA, and numbers indicate pPAAs 3–6. Note that the
HA is formed incompletely in the tcf21mutant embryos (V, X, X0). The light green color in (K0) and (L0) marks the nkx2.5+ head muscles. The nkx2.5+ endothelial
cells are indicated by dark green. Lateral views (first, third, and fifth column) and ventral views (second, fourth, and sixth column). Sample number of imaged
embryos is indicated as a total for the ventral and lateral views.expression driven by the two ventral head endothelial progenitor
markers tcf21 and nkx2.5 is almost always absent in Mtz-treated
flk:GFP; tcf21:mCherry-NTR and nkx2.5:ZsYellow; tcf21:
mCherry-NTR embryos (Figures 3J–3Q, 3L0, 3M0, 3P0, and 3Q0
and Figures 3R–3Y, 3T0, 3U0, 3X0, 3Y0, respectively). Moreover,
following tcf21+ cells in individual tcf21:mCherry-NTR embryos
that co-express the endothelial marker flt1:YFP indicates that
tcf21+ cells are completely ablated at 2 dpf but that the pPAAs
show few or no defects by 5 dpf (Figures S1F–S1M). This indi-
cates that most of the ventral head vasculature is able to form
without its progenitors, most likely explained by an alternate
cell population that compensates for the lost ventral head vascu-
lature progenitors.Current Biology 25, 2099–Tcf21 Is Required for Head Muscle Formation and
Together with Nkx2.5 for Head Vasculature Formation
To determine whether tcf21 itself is required for the formation of
the head muscles and the ventral head endothelium, we gener-
ated a tcf21 deletion mutant (Figure S2A). In tcf21 mutant em-
bryos, all head muscles with the exception of the eye and
neck-homologous muscles are either missing or severely
reduced. Some fibers of the intermandibularis anterior, the inter-
hyoideii, and the most posterior head muscles are frequently still
present (Figures 4A–4H, 4C0, 4D0, 4G0, and 4H0), while heart
morphology and function do not show a discernible defect (Fig-
ures S2B, S2E, and S2H) and the cartilage is only mildly affected
(Figures S2C, S2D, S2F, and S2G). Time-lapse microscopy2110, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2103
Figure 5. Specification of the Ventral Head
Vasculature Requires the Combined Activ-
ities of Tcf21 and Nkx2.5
(A-P0) Live images and schematic diagrams of
embryos of indicated stages and genotypes car-
rying the indicated transgenes. Squares in (A), (E),
(I), and (M) indicate magnified regions shown in (B),
(F), (J), and (N). Numbers indicate PAAs 3–6 in (B),
(F), (J), and (N). Arrowheads indicate the HA.
Lateral views (first and second column) and ventral
views (third, fourth, and fifth column). Anterior is to
the left. The scale bar represents 100 mm.Note that
the images in (B), (F), (J), and (N) are thresholded
using an ImageJ custom-written macro to only
show the endothelial cells (see ImageJscripts2.ijm
in Data S1).
(Q) Quantification of the contribution of nkx2.5+
cells to the PAAs 3–6 in wild-type (includes
tcf21-/+; nkx2.5-/+ and tcf21-/+; nkx2.5-/+ em-
bryos, n = 37), tcf21 mutant (includes tcf21/;
nkx2.5-/+ embryos, n = 13), nkx2.5 mutant (in-
cludes nkx2.5/; tcf21-/+ embryos, n = 10), and
tcf21; nkx2.5 double mutant embryos (n = 10). In-
dividual data points and the mean with the SEM
are indicated. See also Figures S2 and S3. In cases
involving tcf21; nkx2.5 double mutant embryos
where contribution of nkx2.5+ cells to PAAs was
ambiguous due to the presence of neighboring
dying nkx2.5+ cells, scoring reflects a baseline
assumption of nkx2.5+ cell contribution.
(R) Quantification of lumenized PAAs of indicated
genotypes at 60 hpf. The sample numbers for each
genotype are: wild-type embryos (includes
tcf21-/+; nkx2.5-/+ and tcf21-/+; nkx2.5-/+ em-
bryos) n = 19, tcf21 mutants (includes tcf21/;
nkx2.5-/+ embryos) n = 5, nkx2.5mutants (includes
nkx2.5/; tcf21-/+ embryos) n = 7, and tcf21;
nkx2.5 double mutant embryos n = 3.shows that tcf21+ cells are born in tcf21 mutant embryos and
initiate their migration into the pharyngeal arches. However,
these cells begin to die around 26 hpf, such that by 60 hpf, few
tcf21+ muscle progenitors remain (Movie S1). This indicates
that Tcf21 is not required for the initial specification and migra-
tion of tcf21+ cells into the pharyngeal arches but rather for the
survival of head muscle progenitors. These observations are
consistent with findings in mice and flies where Tcf21 pro-
motes—in mice together with its paralog musculin/MyoR—the
specification and survival of progenitors for a subset of jaw mus-
cles and longitudinal gut muscles, respectively [22, 36].2104 Current Biology 25, 2099–2110, August 17, 2015 ª2015 Elsevier Ltd All rights reservedIn contrast to the clear requirement for
tcf21 in the head muscles, the ventral
head vasculature is only mildly affected
in tcf21mutant embryos. While the hypo-
branchial artery often fails to connect
completely or is misshapen, all pharyn-
geal arch arteries form and become even-
tually lumenized (Figures 4Q–4X, 4S0, 4T0,
4W0, 4X0, and 5R; Table S2). Since tcf21+
cells contribute to both head muscle and
head endothelium but only the head mus-
cles require Tcf21 activity, it is likely thatTcf21 acts together with another transcription factor to promote
specification and/or survival of tcf21+ endothelial cells. One
candidate for such a transcription factor is Nkx2.5, as a subset
of the tcf21+ cells co-express nkx2.5 before mesoderm migra-
tion into the pharyngeal arches (Figures 1D and 1E). Moreover,
nkx2.5-expressing (nkx2.5+) cells also contribute to the pPAAs
[8], and perduring fluorescent proteins expressed from the
tcf21 and nkx2.5 promoters co-label the ventral head endothe-
lium (Figures 1L, 1M, 5A–5D, and 5D0). To test this idea, we
analyzed the formation of the ventral head endothelium in tcf21
mutant, nkx2.5mutant, and tcf21;nkx2.5 doublemutant embryos
transgenic for flk:mCherry to label endothelial cells and
nkx2.5:ZsYellow to label pPAA progenitors. In contrast to
nkx2.5 morpholino knockdown experiments [8], which have
recently been reported to be error prone [37], we find that the
pPAAs are present at 60 hpf in tcf21 mutant, nkx2.5 mutant,
and tcf21;nkx2.5 double mutant embryos, although pPAAs oc-
casionally failed to lumenize in nkx2.5 mutant, tcf21 mutant,
and tcf21;nkx2.5 double mutant embryos (Figure 5R). This result
indicates, unexpectedly, that tcf21 and nkx2.5 are not required
for pPAA formation. However, our observation that non-tcf21+
cells can compensate for ablated tcf21+ pPAA progenitors in
forming the pPAAs (Figures 3J–3Q, 3L0, 3M0, 3P0, and 3Q0) sug-
gests that tcf21 and nkx2.5 might be required for pPAA progen-
itor formation but dispensable for other cells to compensate in
pPAA formation. To address this possibility, we asked whether
pPAA progenitors are specified, survive, and contribute to the
pPAAs in tcf21;nkx2.5 double mutant embryos. To assess spec-
ification, we tested whether pPAA progenitors initiate the
expression of the endothelial differentiation marker tie1 in
tcf21:mCherry transgenic embryos [38, 39]. Although we find
that a subset of the tcf21+ cells express tie1 in the pharyngeal
arches at 36 hpf in all four genotypes—wild-type, tcf21 mutant,
nkx2.5mutant, and tcf21;nkx2.5 double mutants—its expression
is mostly absent from pharyngeal arches 3 and 4 and weaker in
the pharyngeal arches 5 and 6 in tcf21;nkx2.5 doublemutant em-
bryos compared to wild-type and tcf21 or nkx2.5 single mutant
embryos (Figure S3 and see file ImageJscripts3.ijm in Data
S1). This suggests that the pPAA progenitors are not fully spec-
ified in the absence of Tcf21 and Nkx2.5 activity.
To test for survival of pPAA progenitors, we followed tcf21;
nkx2.5 co-expressing cells in tcf21:mCherry-NTR and
nkx2.5:ZsYellow double transgenic embryos by time-lapse mi-
croscopy. Such embryos have three differently labeled fluores-
cent cell populations: nkx2.5+-only cells, tcf21+-only cells, and
nkx2.5+; tcf21+ cells. To follow these three cell populations
separately, we segmented the movies based on the fluores-
cence intensities of the tcf21:mCherry-NTR and nkx2.5:ZsYellow
transgenes and assigned each cell population a pseudo color
using a custom-written ImageJ script (see file ImageJscript-
s1.ijm in Data S1). This analysis shows that nkx2.5+; tcf21+
pPAA progenitor cells die between 40 and 42 hpf in tcf21;nkx2.5
double mutant embryos, but not in wild-type, tcf21 mutant, or
nkx2.5 mutant embryos (Movie S2), suggesting that the failure
in proper specification compromises the survival of pPAA pro-
genitors 4–6 hr later.
We assessed the contribution of pPAA progenitors to the
pPAAs in wild-type, tcf21 mutant, nkx2.5 mutant, and tcf21;
nkx2.5 double mutant embryos in two transgenic backgrounds:
in the first, we used flk:mCherry as a marker for the pPAAs and
nkx2.5:ZsYellow as a marker for the pPAA progenitors. In the
second, we used flk:GFP as a marker for the pPAAs and
tcf21:mCherry as a marker for the pPAA progenitors. Similar to
what we see in wild-type embryos, we find that in nkx2.5mutant
embryos, almost all pPAAs express ZsYellow from the nkx2.5
promoter or mCherry from the tcf21 promoter and are derived
from pPAA progenitors (Figures 5A–5H, 5D0, 5H0, and 5Q; Fig-
ure S2I; see file ImageJscripts2.ijm in Data S1). Also, the pPAAs
in tcf21 mutant embryos are mostly composed of nkx2.5+ and
tcf21+ pPAA progenitors, although some embryos occasionallyCurrent Biology 25, 2099–display a pPAA that is only partly composed of pPAA progen-
itors (Figures 5I–5L, 5Q, and S2I). In contrast, the pPAAs in
tcf21;nkx2.5 double mutant embryos are mostly devoid of
pPAA progenitor cells, displaying a small contribution of
nkx2.5+ and tcf21+ cells, if any, to the pPAAs (Figures 5M–
5P, 5Q, and S2I). Similarly, the nkx2.5+ and tcf21+ HA progen-
itors are absent in tcf21; nkx2.5 double mutant embryos.
However, in contrast to the pPAAs that form in the absence
of pPAA progenitors, the HA recovers only partly and never
connects to the LDA in the absence of its progenitors (Figures
5O and 5P; Table S2). This suggests that in contrast to the
pharyngeal head muscle progenitors, which require only
Tcf21 activity for their formation, the pPAA and HA progenitors
require the combined activity of Tcf21 and Nkx2.5 for their
specification and survival, a requirement that is masked in the
pPAAs by compensation by other cells in the absence of the
pPAA progenitors.
The Pharyngeal Arch Arteries Are Derived from the
Interface between the Pharyngeal and Cardiac
Mesoderm
To locate more precisely where pPAA progenitors are born, we
used time-lapse microscopy to follow nkx2.5+/tcf21+ cells in
the head mesoderm from the 15-somite stage (16.5 hpf) to 44
hpf (Movie S3). Consistent with our expression analysis (Fig-
ure 1), nkx2.5+ cells are flanked anteriorly and posteriorly by
tcf21+ cells, and cells at the borders between the expression do-
mains co-express both transcription factors at the 15-somite
stage. Thus, the expression of tcf21 and nkx2.5 delineate three
different cell populations in the head mesoderm: tcf21+ cells,
nkx2.5+ cells, and tcf21+/nkx2.5+ cells.
We followed these three cell populations separately by seg-
menting the movies based on the fluorescence intensities of the
tcf21:mCherry-NTR and nkx2.5:ZsYellow transgenes and
pseudo-coloring each cell population as described above
(see ImageJscripts1.ijm in Data S1). This analysis shows that
a few nkx2.5+ cells move medially to contribute to the heart
while others move laterally and ventrally to form the pericardial
sac. In contrast, the cells in the two tcf21+ domains move ante-
riorly with the cells in the posterior tcf21 expression domain
moving faster, such that by 24 hpf, the posterior cells almost
reach the anterior cells and bridge the initial gap that was
created by the nkx2.5+-only cells. During this migration toward
the anterior, the tcf21+ and tcf21+/nkx2.5+ cells coalesce into
individual clusters that then form the inner cores of the pharyn-
geal arches. The cells in the anterior tcf21 expression domain
contribute to the core of the first and second pharyngeal
arch, while the cells in the posterior tcf21 expression domain
contribute to the posterior five pharyngeal arches and then
form dorsal head muscles and part of the LDA. The tcf21/
nkx2.5 co-expressing cells from the borders between the
nkx2.5 and tcf21 expression domains also move anteriorly,
similar to the tcf21+ cells. However, in contrast to the tcf21+
cells, which populate the dorsal part of the inner core of the
pharyngeal arches, the tcf21+/nkx2.5+ cells move to the ventral
part of the pharyngeal arches and ultimately form ventral head
muscles and the HA, the pPAAs, and the VA. These observa-
tions indicate that the progenitors of the ventral head vascula-
ture, including the pPAA progenitors, originate from the anterior2110, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2105
and posterior borders of the nkx2.5 expression domain, where
it overlaps with the tcf21 expression domain.
Dorsal Head Endothelial Cells Compensate for the Loss
of Pharyngeal Arch Artery Progenitors
Although pPAA progenitors are lost in embryos with ablated
tcf21+ cells and in tcf21/; nkx2.5/ double mutant em-
bryos, the pPAAs still form. To determine the cellular origin for
this vascular plasticity, we reasoned that a likely source of the
compensating cells in embryos with lost pPAA progenitors is
other, nearby endothelial cells. To test this idea, we followed
endothelial cells marked by flk:GFP or flt1:YFP in Mtz-treated
non-tcf21:mCherry-NTR and tcf21:mCherry-NTR embryos. In
wild-type embryos, the tcf21+/nkx2.5+ pPAA progenitors
migrate dorsally to connect with the LDA (Figures 6A and 6B;
Movies S3 and S4). By contrast, in embryos with ablated pPAA
progenitors, endothelial cells from either the LDA or the primary
head sinus migrate in the opposite direction ventrally to fill in the
missing pPAAs (Figures 6C and 6D; Movie S4). Co-staining for
the pharyngeal endoderm shows that the compensating endo-
thelial cells populate the same position in the pharyngeal arches
in tcf21+ cell-ablated embryos as the pPAAs in control embryos
(Movie S5). This suggests that the dorsal head vasculature is the
source for the compensating cells. To confirm this observation,
we generated embryos that express the photoconvertible Kaede
protein in a mosaic fashion in all endothelial cells. For this, we in-
jected UAS-Kaede DNA into cdh5:Gal4FF transgenic embryos
[40]. cdh5 is a pan-endothelial marker [41], and Kaede protein
changes its fluorescence after exposure to UV light from green
to red [42]. We imaged these embryos at 48 hpf before and after
photoconversion of a region of cells in the dorsal head vascula-
ture using a 405-nm laser. We then allowed the embryos to
develop for 24 hr and imaged the embryos again at 72 hpf to
determine the position of the photoconverted cells (Figure 6E).
Consistent with our time-lapse analysis, we find that in embryos
with ablated pPAA progenitors, photoconverted red endothelial
cells from the LDA and primary head sinus move ventrally to
form the pPAAs (Figures 6F–6I). By contrast, photoconverted
red endothelial cells from the LDA and primary head sinus do
not move ventrally to contribute to the pPAAs in embryos in
which the pPAA progenitors were not ablated (Figures 6J–6M).
As in embryos with ablated pPAA progenitors, endothelial cells
from the LDA and primary head sinus also restore the pPAAs
in tcf21/; nkx2.5/ double mutants, in which the pPAA pro-
genitors fail to specify properly and die; time-lapse analysis of
embryos carrying the endothelial marker flk:mCherry and the
pPAA progenitor marker nkx2.5:ZsYellow shows that endothelial
cells from the dorsal head vasculature sprout and migrate
ventrally from the dorsal head vasculature to form the pPAAs
(Figures 6O, 6Q, and 6S; Movie S6). In contrast, in wild-type con-
trol embryos, the pPAAs are formed by the nkx2.5+ pPAA pro-
genitors (Figures 6N, 6P, and 6R; Movie S6). In tcf21 mutant
embryos, endothelial cells from the dorsal head vasculature oc-
casionally contributed to the pPAAs, consistent with the obser-
vation that the pPAA progenitors are occasionally reduced in
number in this genetic scenario (Figures 5I, 5J, and 5Q).
Together, these observations indicate that the dorsal head
vasculature is the source for the plasticity of the pPAAs in sce-
narios where the pPAA progenitors are absent.2106 Current Biology 25, 2099–2110, August 17, 2015 ª2015 ElsevieDISCUSSION
Our results suggest a model in which tcf21+, tcf21+/nkx2.5+,
and nkx2.5+ mesoderm give rise to head muscles, much of the
ventral head vasculature, and the heart (Figure 7). According to
this model, the pharyngeal head muscle progenitors are born
in the two domains of the tcf21+ mesoderm that abut the
nkx2.5+ heart mesoderm at its anterior and posterior borders.
The anterior and posterior borders of the heart mesoderm, where
cells express both tcf21 and nkx2.5, give rise to the progenitors
of much of the ventral head vasculature and the ventral pharyn-
geal head muscles, with cells at the anterior border giving rise to
the HA and cells at the posterior border forming the pPAAs. Dur-
ing pharyngeal arch formation, the nkx2.5+ cells streammedially
and laterally to contribute to the heart and the tissues of the peri-
cardium, respectively, while the tcf21+/nkx2.5+ vascular and
muscle progenitors at the anterior and posterior borders move
closer to each other and populate the ventral cores of the
pharyngeal arches—the dorsal cores are populated by tcf21+
head muscle progenitors. These morphogenetic movements
bring the progenitors of the HA and pPAAs, respectively, anterior
and dorsal to the forming heart and provide a cellular explanation
for the co-occurrence of many craniofacial and cardiac birth de-
fects [4, 15, 16].
The related cellular origins of the head muscles, ventral head
vasculature, and part of the heart are also reflected on a molec-
ular level. Our and others’ genetic analyses show that the tcf21+
pharyngeal head muscle progenitors require Tcf21 activity for
their specification [22, 26]. Similarly, we find that the tcf21+/
nkx2.5+ vascular HA and pPAA progenitors require the joint ac-
tivity of Tcf21 and Nkx2.5 for their specification, and previous
studies have shown that Nkx2.5 is required for ventricular iden-
tity in the heart [43–46]. Together, these observations suggest
that the different combinations of these two transcription factors
divide the head mesoderm into three domains that give rise to
three spatially and molecularly related structures: (1) the pharyn-
geal head muscles, (2) the HA and the pPAAs, and (3) part of the
heart (Figure 7). This not only adds amolecular explanation to the
cellular explanation for the co-occurrence of many craniofacial
and cardiac birth defects [4] but also points to the molecular ma-
chinery that may be necessary to make pPAA progenitor cells
in vitro.
Intriguingly, we find that embryos with ablated ventral head
vascular progenitors remake their posterior pPAAs from endo-
thelial cells in the dorsal head vasculature. The compensating
blood vessels in embryoswith ablated pPAAs invade the pharyn-
geal arches up to a day later and from the opposite direction than
the developing pPAAs in wild-type embryos, suggesting that the
molecular mechanism underlying this plasticity is distinct from
the guidance program in wild-type embryos. In principle, there
are several possible scenarios for how compensating endothelial
cells are recruited to re-form the lost pPAAs. Dying pPAA pro-
genitors could secrete an endothelial attractant that then recruits
nearby endothelial cells. However, given the 24-hr time span
over which the pPAAs are re-formed, it is also likely that the dying
pPAA progenitors activate adjacent cells to express an endothe-
lial attractant to recruit compensating endothelial cells. Alterna-
tively, the wild-type PAAs could physically block dorsal endothe-
lial cells from moving in, such that when the wild-type PAAs arer Ltd All rights reserved
Figure 6. Endothelial Cells from the Dorsal
Head Vasculature Compensate for Lost
pPAAs in tcf21 Cell-Ablated Embryos and
tcf21–/–; nkx2.5–/– Embryos
(A–D) Live images of two embryos of indicated
stages and genotypes carrying the indicated
transgenes and treated with Mtz as described in
Figure 3A. Numbers in (A) and (C) indicate the PAA,
and arrows in (B) and (D) indicate the pPAAs. Im-
ages correspond to the first and last frames in
Movie S4.
(E) Schematic of experimental design. cdh5:
Gal4FF; tcf21:mCherry-NTR embryos were in-
jected at the one-cell stage with UAS-Kaede DNA.
The embryos were treated with Mtz to ablate the
tcf21+ cells as shown in Figure 3A. Embryos with
green Kaede expression in the dorsal head
vasculature were imaged, Kaede was photo-
converted from green to red, and the contribution
of endothelial cells in the dorsal head vasculature
to the pPAAs was assessed 24 hr later.
(F) Mtz-treated cdh5:Gal4FF; tcf21:mCherry-NTR
embryo with mosaic green Kaede expression in
the head vasculature. Dying tcf21+ cells are ex-
pressing mCherry protein.
(G) Same embryo as in (F), but Kaede-expressing
endothelial cells in the dorsal head vasculature
have been photoconverted from green to red.
Region of photoconversion is marked by a rect-
angle in (F).
(H and I) Same embryo as in (F) 24 hr post-pho-
toconversion. Photoconverted dorsal endothelial
cells have migrated ventrally to compensate for
the ablated pPAA progenitors and contribute to
the pPAAs (arrowheads in I). Square in (H) in-
dicates magnified region shown in (I) (n = 2).
(J) Mtz-treated cdh5:Gal4FF embryo not trans-
genic for tcf21:mCherry-NTR with mosaic green
Kaede expression in the head vasculature (n = 8).
(K) Same embryo as in (J), but Kaede-expressing
endothelial cells in the dorsal head vasculature
have been photoconverted from green to red.
Region of photoconversion is marked by a rect-
angle in (J).
(L and M) Same embryo as in (J) 24 hr post-pho-
toconversion. Photoconverted, dorsal endothelial
cells do not migrate ventrally and do not contribute
to the pPAAs (arrowheads in M). Square in (L) in-
dicates magnified region shown in (M).
Scale bars represent 100 mm. Anterior is to the left,
and dorsal is up.
(N–S0 0) Live images of two embryos of indicated
stages and genotypes carrying the indicated
transgenes. Numbers in (N)–(S) indicate the PAA,
and arrows in (O), (O0 0 ), (Q), (Q0 0), (S), and (S0 0)
indicate endothelial cells that are migrating into
arch 6 to form PAA 6. (O0), (Q0), and (S0) show the
green channel only (nkx2.5:ZsYellow), and (O0 0),
(Q0 0), and (S0 0 ) show the red channel only
(flk:mCherry). Images correspond to time points
51, 51.5, and 52 hpf (frames 11, 12, and 13) in
Movie S6. Lateral views. Anterior is to the left.
Scale bars represent 100 mm.
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Figure 7. Schematic Depicting the Cellular Origin and Genetic Requirements for Head Muscle, Ventral Head Vasculature, and Heart
Formation
(A) At 16 hpf (14-somite stage), nkx2.5+ only cells (yellow) are sandwiched between anterior and posterior domains of tcf21+ only cells (blue). nkx2.5+/tcf21+ cells
(green) are found at the interface of the nkx2.5+ and tcf21+ domains, where these two domains overlap. Anterior tcf21+ and nkx2.5+/tcf21+ populations will give
rise to the mesodermal cores of pharyngeal arches (PAs) 1 and 2, while posterior tcf21+ and nkx2.5+/tcf21+ populations will form the mesodermal cores of PAs
3–7. nkx2.5+/tcf21+ cells from the anterior domain will give rise mostly to the ventral head muscles derived from PAs 1–2 and the hypobranchial artery (HA), while
nkx2.5+/tcf21+ cells from the posterior domain will give rise mostly to the ventral head muscles derived from PAs 3–7 and the posterior pharyngeal arch arteries
3–6 (pPAAs). tcf21+ cells from the anterior domain will give rise to dorsal and some ventral head muscles from PAs 1–2, while tcf21+ cells from the posterior
domain will give rise to dorsal and some ventral head muscles from PAs 3–7. nkx2.5+ cells will give rise to the heart and pericardium. Dorsal view.
(B) As the PAs form, tcf21+ and nkx2.5+/tcf21+ cell clusters are found at the centers of each developing arch. tcf21+ cells predominate at the anterior and dorsal
ends of PA1, the dorsal portions of PAs 2–6, and the dorsal and posterior portions of PA 7. nkx2.5+/tcf21+ cells predominate in the ventral portions of the
developing arches. nkx2.5+ cells are found medially in the developing heart tube as well as laterally in the developing pericardium. Dorsal view.
(C) Top: tcf21+ cells give rise to dorsal muscles derived from PAs 1 to 7, as well as some ventral muscle fibers from PA 1 and PA 7. nkx2.5+/tcf21+ cells give rise to
the ventral muscles as well as some dorsal muscle fibers of PAs 1–7. Eye and neckmuscles are derived from non-nkx2.5/non-tcf21 cells (black). Bottom: nkx2.5+
cells give rise to the heart. nkx2.5+/tcf21+ cells give rise to the HA, pPAAs 3–6, and the ventral aorta (VA). Pharyngeal arch artery 1 (PAA1), the opercular artery
(ORA), and much of the LDA derive from non-nkx2.5-/non-tcf21 cells (white). Part of the early LDA is derived from tcf21+ cells (data not shown). Lateral view.
(D) Top: nkx2.5/; tcf21/ embryos lose most PA-derived muscles, with some fibers from PA 1- and PA 7-derived muscles remaining. Bottom: the HA is
missing in nkx2.5/embryos. pPAAs 3–6 are present but are now derived from compensating non-nkx2.5/non-tcf21 cells originating in the dorsal head
vasculature. Lateral view.lost, dorsal endothelial cells are unbounded and able to migrate
in to form the missing arteries.
More generally, this vascular plasticity allows the embryo to
correct for minor defects in pPAA development to sustain proper
circulation. Since congenital heart defects affect almost 1% of
births per year in the United States [47, 48], the heart and its
associated great vessels seem to be especially vulnerable to ge-
netic and traumatic perturbation, suggesting that such a
vascular buffering capacity might be essential. Moreover, if this
plasticity proves to be a broader theme in development and
maintenance of the vasculature, it might explain why many
genes expressed in endothelial cells do not seem to be essential
[37] and may warrant a closer phenotypic analysis.EXPERIMENTAL PROCEDURES
Zebrafish Strains
Embryos were staged as previously described [29]. tcf21D236 (this study) and
nkx2.5vu179 [44] homozygous mutant embryos were generated by inbreeding
heterozygous adults. Mutant, heterozygous, and wild-type embryos were
distinguished through PCR amplification of the mutated locus based on
size for tcf21D236 and based on restriction digest with HinfI (New England
Biolabs) for nkx2.5. All vertebrate animal work was performed at the facilities
of the Skirball Institute at the NYU Langone Medical Center (NYULMC).
NYULMC Animal Care & Use Program is fully accredited by the Association
for Assessment and Accreditation of Laboratory Animal Care International2108 Current Biology 25, 2099–2110, August 17, 2015 ª2015 Elsevie(AAALAC). The Animal Care and User Program at NYULMC is in full compli-
ance with PHS policy, and the Assurance of Compliance Number with the
PHS is A3435-01. This study was approved by the NYULMC Animal Care
& Use Program under protocol no. 110805-03. For a complete list of zebra-
fish strains and genotyping protocols, see Supplemental Experimental
Procedures.
Mtz/NTRo-Mediated Cell Ablation
For tcf21+-cell ablation, tcf21:mCherryNTRo embryos were bathed in em-
bryo water containing 10 mM Mtz (Sigma, M1547) as previously described
[49] from 9 hpf to 48 hpf—or in the case of movies beginning before 48
hpf, 9 hpf to 36hpf—and transferred to embryo water without Mtz until
the embryos were analyzed or until 5 dpf. Live embryos were mounted
in agar, and z stacks were collected on a Leica SP5 II confocal micro-
scope. ImageJ (NIH) was used to create maximum projections of the z
stacks.
Cre-Mediated Fate Mapping
For 4-hydroxytamoxifen (4-HT, Sigma Aldrich) labeling, 9 hpf tcf21:Cre-ER;
bactin2:RSG embryos were placed in embryo medium with 4-HT added to
a final concentration of 5 mM, from a 1 mM stock solution made in 100%
ethanol. After 15 hr, embryos were washed and placed in embryo medium
without 4-HT until the embryos were 4.5 dpf. Live embryos were mounted
in agar, z stacks were collected on a Leica SP5 II confocal microscope
and genotyped for the tcf21 mutation. GFP-labeled cells were manually
scored by visual inspection using ImageJ (NIH). Embryos with putative
GFP-labeled muscle fibers and endothelial cells were fixed and co-stained
for MHC and Cdh5, respectively, to confirm the identity of the GFP-labeled
cells.r Ltd All rights reserved
Kaede Photoconversion-Mediated Fate Mapping
To follow endothelial cells using photoconversion of Kaede, we injected
cdh5:Gal4FF transgenic control embryosand cdh5:Gal4FF; tcf21:mCherryNTRo
double transgenic embryos [40] with 30 ng/ul pDestTol2pA2-UAS-Kaede
plasmid DNA [50] and 25 ng/ul tol2 mRNA. Tol2 enhances the integration of
DNA constructs flanked with tol2 cis-acting sites into the genome [51].
Selected 48 hpf embryos with transient expression of green fluorescent Kaede
protein in the head vasculature were mounted in agar and imaged on a Leica
SP5 II confocal microscope. Using the 405-nm laser line, Kaede protein in
endothelial cells of the LDA and PHS was photoconverted from green fluores-
cence to red fluorescence, and the embryo was imaged again. Embryos were
removed from the agar, raised to 72 hpf, mounted in agar again, and imaged
live to record the position of the photoconverted, Kaede-expressing endothe-
lial cells.
Live Imaging and Time-Lapse Imaging and Analysis
For live imaging, embryos were mounted in 0.5% low-melt agarose/fish water
(0.3g/L Instant Ocean Salt, Marineland Labs). z stacks were collected with a
Leica 203 water dipping lens (NA 0.5) or a Leica 403 water dipping lens (NA
0.8) and a Leica SP5 II confocal microscope equipped with HyD detectors
(Leica Microsystems) and a heated stage (Warner Instruments). The tempera-
ture of the water bath was monitored and maintained between 27.9C and
28.4C. z stacks evaluated by image segmentation were collected in the
photon-counting mode. Embryos were genotyped by PCR as described in
Supplemental Experimental Procedures.
Heartbeat Frequency Measurements
For determining the heartbeat frequency, we counted the heartbeat of individ-
ual embryos three times for 15 s each and averaged the heartbeat frequency
for each embryo.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, two tables, six movies, and one data file and can be found
with this article online at http://dx.doi.org/10.1016/j.cub.2015.06.076.
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